DICERNA PHARMACEUTICALS INC - COM (DRNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2022

Type / Class
Equity / COM
Symbol
DRNA
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of DICERNA PHARMACEUTICALS INC - COM (DRNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q2 0 $0 -$76,000 0
2022 Q1 2,000 $76,000 $38.00 1
2021 Q4 2,000 $76,000 -$1,273,860,578 $38.00 1
2021 Q3 63,329,967 $1,276,718,425 -$57,244,649 $20.16 169
2021 Q2 60,972,167 $2,275,287,745 -$67,012,413 $37.32 200
2021 Q1 63,002,137 $1,604,893,307 +$41,073,595 $25.57 178
2020 Q4 63,106,309 $1,390,484,768 +$60,510,868 $22.03 170
2020 Q3 60,473,216 $1,088,924,535 -$58,889,661 $17.99 169
2020 Q2 61,793,473 $1,568,418,793 +$31,941,338 $25.40 166
2020 Q1 61,044,940 $1,123,360,083 +$60,029,572 $18.37 142
2019 Q4 57,431,641 $1,265,206,552 +$6,643,926 $22.03 166
2019 Q3 57,953,858 $832,378,421 +$25,081,211 $14.36 110
2019 Q2 56,089,372 $883,405,804 -$32,840,664 $15.75 97
2019 Q1 58,591,524 $858,256,871 +$27,387,868 $14.65 96
2018 Q4 58,204,159 $622,148,736 +$32,613,468 $10.69 101
2018 Q3 54,910,045 $837,931,062 +$135,552,124 $15.26 96
2018 Q2 37,196,165 $455,641,184 +$71,106,242 $12.25 84
2018 Q1 40,595,617 $388,092,257 +$15,869,300 $9.56 70
2017 Q4 39,172,420 $352,414,289 +$171,920,888 $9.03 50
2017 Q3 11,327,081 $65,127,184 -$396,824 $5.75 35
2017 Q2 11,564,180 $36,658,101 -$194,819 $3.17 33
2017 Q1 11,626,072 $39,528,109 +$1,995,104 $3.40 43
2016 Q4 11,260,391 $32,433,092 -$3,621,732 $2.88 49
2016 Q3 12,098,029 $71,138,000 -$444,711 $5.88 47
2016 Q2 12,496,340 $37,476,000 -$8,469,886 $3.00 51
2016 Q1 14,969,219 $80,226,000 -$3,595,897 $5.36 55
2015 Q4 15,569,924 $184,806,731 +$20,025 $11.87 57
2015 Q3 15,639,615 $128,392,648 -$6,309,583 $8.21 50
2015 Q2 15,239,178 $212,567,020 +$33,334,576 $13.95 66
2015 Q1 12,680,355 $304,458,533 +$22,310,445 $24.03 52
2014 Q4 11,902,864 $195,986,843 -$6,677,856 $16.47 43
2014 Q3 11,749,517 $149,558,921 -$5,232,882 $12.73 40
2014 Q2 12,148,332 $274,189,168 -$8,428,283 $22.57 39
2014 Q1 12,350,085 $348,805,000 +$348,805,000 $28.25 42